Filing Details

Accession Number:
0001127602-22-002777
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-01 16:43:23
Reporting Period:
2022-01-28
Accepted Time:
2022-02-01 16:43:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757584 David James Clark One Cvs Drive
Woonsocket RI 02895
Svp, Cont & Chief Acct Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-28 6,059 $102.26 23,556 No 4 M Direct
Common Stock Disposition 2022-01-28 6,059 $109.00 17,497 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-01-28 6,059 $0.00 6,059 $102.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-04-01 2022-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Restricted) 16,921 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $54.19 2020-04-01 2029-04-01 24,240 24,240 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 7,513 7,513 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 9,050 9,050 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 7,044 7,044 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-04-01 24,240 24,240 Direct
2025-04-01 7,513 7,513 Direct
2024-04-03 9,050 9,050 Direct
2023-04-01 7,044 7,044 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Options became exercisable in four equal annual installments beginning on 4/1/2016.
  3. Options became exercisable in four equal annual installments, commencing 4/1/2020.
  4. Options became exercisable in four equal annual installments, commencing 4/1/2019.
  5. Options became exercisable in four equal annual installments beginning on 4/3/2018.
  6. Options became exercisable in four equal annual installments beginning on 4/1/2017.